• Hastings Law Journal
  • HMS CME Writing, Publishing and Social Media
  • ACP Negotiation Session
  • Top 10
  • Tax Cuts and Jobs act
  • Antitrust and Pharmaceuticals
  • The U.S. Opioid Epidemic: Where Do We Go From Here?
  • Pediatric Exclusivity
  • The Ethics of Health Care Reform
  • Determinants of Market Exclusivity

Dr. Sinha is a Regulatory Science Fellow at the Harvard-MIT Center for Regulatory Science, within the Harvard Program in Therapeutic Science (HiTS) at Harvard Medical School. He is also affiliated with the Program On Regulation, Therapeutics, And Law (PORTAL), within the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine at Brigham and Women’s Hospital. Medical publications have appeared in JAMA, JAMA Internal Medicine, CHEST, PLOS Medicine, Health Affairs (forthcoming), and the American Journal of Bioethics. His legal scholarship includes articles in the American Journal of Legal Medicine, the American Journal of Law and Medicine, the Journal of Law, Medicine & Ethics,  the Harvard Law & Policy Review, the Food and Drug Law Journal, the Stanford Law & Policy Review, and the Hastings Law Journal (forthcoming).